BP p.l.c.
Transaction in Own Shares
BP p.l.c. (the "Company") announces that on 31 October 2024 it has purchased, in accordance with the authority granted by shareholders at the 2024 Annual General Meeting of the Company, a total of 4,220,000 of its ordinary shares of $0.25 each ("Shares") on the London Stock Exchange and Cboe (UK) as part of the buyback programme announced on 29 October 2024 (the "Programme") and as detailed below:
| | London Stock Exchange | Cboe (UK)/BXE | Cboe (UK)/CXE |
| Number of Shares purchased: | 2,960,000 | 420,000 | 840,000 |
| Highest price paid per Share (pence): | 378.15 | 378.10 | 378.15 |
| Lowest price paid per Share (pence): | 372.05 | 372.05 | 372.05 |
| Volume weighted average price paid per Share (pence): | 375.1380 | 375.0784 | 375.0887 |
The Company intends to cancel these shares in accordance with the authority granted by its shareholders at the Company's 2024 Annual General Meeting.
The schedule below contains detailed information about the purchases made by Citigroup Global Markets Limited (intermediary code: SBILGB2L) on the date of purchase as part of the Programme.
Further enquiries:
bp Investor Relations +44(0) 207 496 4000
Schedule of Purchases
Shares purchased: BP p.l.c. (ISIN CODE: GB0007980591)
Aggregate information:
| Venue | Volume-weighted average price (pence) | Aggregated volume |
| London Stock Exchange | 375.1380 | 2,960,000 |
| Cboe (UK)/BXE | 375.0784 | 420,000 |
| Cboe (UK)/CXE | 375.0887 | 840,000 |
Individual transactions:
To view details of the individual transactions, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/4809K_1-2024-10-31.pdf
The above Transaction in Own Shares announcement is prepared on a trade basis. It is expected the shares purchased will be delivered to the Company in two working days.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
